It is prevalently known that tumour cells prefer inefficient cellular glycolysis, but no one has proved yet the exact reason of using ineffective cellular respiration mechanism of tumour cells. However, through our research, we have investigated that it is highly related to the lack of intracellular calcium ion because as the insufficient calcium ion causes dysfunction of mitochondria which releases reactive oxygen species (ROS), it causes mitochondrial protein mutation such as TDP-43, FUS and SOD1. Therefore, endoplasmic reticulum (ER) gets stressed and it ultimately causes alteration of RNA synthesis.

Author pronuvia

Pronuvia is dedicated to improving the lives of patients with ongoing clinical trials and research. We are also focused on lowering health care costs by developing simple but innovative and effective treatments. Bringing optimum health to general public affordably and painlessly is the grand ambition of Pronuvia. Our research continues.

This website is intended to inform and educate medical professionals. It is not intended for patients. It also does not seek to make claims about the effectiveness of SAC calcium in medical treatment.

Regulated calcium intake can have manifold health effects. Too much or too little calcium and even wrong types of calcium can affect our health negatively. Only ionic calcium plays important physiological functions in our body, and yet many people have chronic ionic calcium deficiency. This site serves to inform medical professionals about ionic calcium’s potential in treating calcium-related diseases by introducing numerous third-party researches done. However, ionic calcium treatment is still an evolving field, and clinical studies are still insufficient to determine its effectiveness.

SAC calcium’s higher solubility provides needed amount of ionic calcium to trigger calcium homeostasis. While Pronuvia’s SAC calcium has Canadian FDA registration (NPN 80043292) and is produced in a FDA compliant laboratory, it has not been approved as a therapeutic treatment.

Patients interested in SAC calcium therapy are advised to consult a participating physician to participate in a clinical trial.